Abbott Labs Profit Doubles On Strong Device And Covid Test Sales Abbott Laboratories said second quarter profits doubled thanks to strong sales of tests for Covid-19 and a return to “pre-pandemic” sales levels for the rest of its diverse portfolio of medical devices and healthcare products.